As darkness enveloped the chilly October evening, my family and I prepared to celebrate Halloween. Our home was embellished with pumpkins, orange and black decorations, and spooky ornaments. We raised a toast to the onset of another holiday season. However, I felt uneasy as I sipped my drink; my body seemed to reject alcohol, a sensation that persisted throughout the holidays in 2021.
Despite altering my diet, the discomfort persisted. By November, a gnawing feeling in my chest had taken hold. A visit to the doctor yielded dismissive advice due to my weight and bloodwork that failed to uncover anything significant.
Seeking further consultation, I visited a gastroenterologist but still felt unheard even after a six-week medication trial. My symptoms worsened, culminating in profound anxiety by January 2022. While vacationing, I noticed a lump in my stomach accompanied by severe back pain.
Upon our return home, I scheduled an ultrasound. The technician’s concern deepened when learning about my family history—my mother passed due to a neuroendocrine tumor when I was young. Her genuine concern amplified my worry.
“I’m so glad you came here today,” she remarked.
Before the day ended, a doctor confirmed a large mass in my pancreas, prompting a desperate quest for immediate further testing. A CAT scan revealed a tumor the size of a softball in the pancreas’s tail, compressing adjacent organs.
Despite multiple consultations, doctors were uncertain about the diagnosis until a biopsy confirmed pancreatic neuroendocrine cancer with metastasis. Neuroendocrine tumors often remain asymptomatic until advanced stages, sometimes releasing hormones that may cause flushing.
My journey continued with surgery in March to remove the tumor, part of my pancreas, spleen, and numerous lymph nodes. Post-recovery scans showed widespread metastasis to bones and liver, reminiscent of my mother’s ordeal.
Treatments over subsequent months were grueling, leading to significant physical decline. Despite temporary stability, the harsh regimens diminished my vitality, confined me to a wheelchair, and even caused a stroke.
Consulting my oncologist last fall brought a sobering conversation regarding my prognosis. With tears suppressed, I learned I might have only two to three years left. My daughter’s presence during the revelation emphasized the cruel reality.
Determined to embrace remaining time, my husband and I embarked on a mission to complete our bucket list. Our venture included an unforgettable trip to Alaska to stand on a glacier. Plans for a family cruise to Turkey, Greece, and Italy highlight intentions to create meaningful experiences with loved ones.
Furthermore, witnessing the Northern Lights unexpectedly in New Jersey felt like divine intervention in appreciating life’s beauty.
“It Shouldn’t Take a Terminal Diagnosis to Start Enjoying Life,”
I knew about neuroendocrine tumors from familial history, yet their rarity leaves many uninformed. Notable figures like Steve Jobs, Aretha Franklin, and Irrfan Khan succumbed to this rare cancer. With limited research and uncertain genetic connections, concern for my children’s future persists.
Encouraged by life’s brevity, I advocate maximizing enjoyment and embracing every moment. Inspired by my mother’s premature passing, this philosophy is conveyed to my children, urging pursuit of life’s diverse opportunities.
Though uncertain of remaining time, I aspire to inspire others, demonstrating unwavering zest for life. Jodi Bremner, 48, resides in New Jersey with her family, committed to enriching their shared journey.
Early Detection of Atherosclerosis and Heart Disease Prevention 
The Measure of Friendship 
A Honeymoon Safari Turns Into a Fight for Survival 
Church Attendance Linked to Increased Sexual Satisfaction for Married Couples 
Dining with Loved Ones May Benefit Blood Sugar Levels 
Urgent Need for Action in East Africa’s Food Crisis